Telehealth providers in Delaware
By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed. Last verified
Telehealth prescribing is allowed in Delaware, including asynchronous care. What Delaware requires of telehealth prescribers and pharmacies, plus listings with their verification status.
Delaware at a glance
- Pharmacy regulator
- Delaware Board of Pharmacy (Division of Professional Regulation)
- 503A framework
- Follows the federal 503A framework
- Telehealth prescribing
- Regulatory: Telehealth allowed
- Asynchronous prescribing
- Regulatory: Async allowed
- Compounded GLP-1 access
- Regulatory: Compounded GLP-1 limited
Telehealth providers serving Delaware
Prescription peptides through an online assessment and a licensed provider review, shipped from a licensed U.S. compounding pharmacy.
Telehealth provider · 17 products · partner lists from $172 a month · Says it serves Delaware (not yet confirmed)
- Prescription only, no research-use-only sales
- Public cancellation and refund policy
We may earn a commission from these links.
Telehealth prescribing rules in Delaware
Title 24, chapter 60 of the Delaware Code (enacted by 83 Del. Laws, c. 52) sets telehealth rules for the listed health professions. Section 6001 defines telemedicine to include secure video conferencing and store and forward transfer, and defines store and forward transfer as a synchronous or asynchronous transmission of a patient's medical information that does not require the patient to be present or to be in real time. Section 6003(a) requires a health-care provider-patient relationship, which may be established in person or through telehealth and must include verifying the patient's location and identity, disclosing the provider's identity and credentials, obtaining consent, establishing a diagnosis through acceptable medical practices, and giving the patient a written visit summary. Section 6003(b) says telehealth services may be synchronous or asynchronous using store-and-forward technology, and may be used to establish the relationship only if the provider determines the provider can meet the same standard of care as an in-person visit. Section 6003(c) prohibits issuing a prescription solely in response to an internet questionnaire, an internet consult, or a telephone consult in the absence of a proper relationship. Section 6004(a) adds that before diagnosis and treatment the provider must do at least one of the following: examine the patient in person, have another Delaware-licensed provider present with the patient, make the diagnosis using audio or visual communication, or meet professional society guidelines for establishing a relationship in evidence-based telemedicine practice. A provider licensed in a state without an applicable interstate compact may treat Delaware patients by telehealth only with an interstate telehealth registration from the Division of Professional Regulation. This record classifies asynchronous prescribing as allowed because section 6003(b) expressly permits asynchronous store-and-forward services and lets telehealth establish the relationship. A prescription issued solely from an internet questionnaire without a proper relationship is prohibited. [2] [3] [4]
Compounded GLP-1 access in Delaware
Delaware patients using an out-of-state telehealth GLP-1 program should confirm the prescriber is Delaware-licensed or holds an interstate telehealth registration, and that the pharmacy holds a Delaware nonresident pharmacy license. [4] [6] [10]
Research use only sellers in Delaware
Only Delaware-licensed pharmacies and licensed nonresident pharmacies may dispense prescription drugs to Delaware patients. "Research use only" peptides sold for human injection are unapproved new drugs under federal law, are not dispensed by a pharmacist, and fall outside Delaware's pharmacy licensing system. Delaware's own food and drug law (16 Del. C. chapter 33, Pure Food and Drugs) prohibits manufacturing or selling an adulterated or misbranded drug (section 3302) but has no separate new-drug approval provision, so the prohibition on selling unapproved new drugs comes from federal law. [6] [8] [11]
How to check a telehealth provider in Delaware
- Confirm the prescriber is licensed or registered to treat patients located in Delaware; the telehealth rules above explain what Delaware requires. [2] [3] [4]
- Ask which pharmacy will fill the prescription and check it in the Delaware Board of Pharmacy (Division of Professional Regulation) license lookup. [1] [5] [6] [7] [9]
- Get the full price in writing first: consult fees, membership fees, and the medication itself.
- Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Delaware. [6] [8] [11]
Common questions in Delaware
Can an out-of-state telehealth doctor prescribe me a GLP-1 in Delaware?
Yes, if the physician holds a Delaware license or a Delaware interstate telehealth registration. Under 24 Del. C. 6002(c), a provider licensed in a state that has not adopted an applicable interstate compact may give telehealth in Delaware only with an interstate telehealth registration from the Division of Professional Regulation. To qualify, the provider must hold an active license in good standing in every state where licensed and must not face a pending complaint or investigation. The provider must still establish a provider-patient relationship under 24 Del. C. 6003. [2] [4]
Can I get a prescription in Delaware just by filling out an online form?
Not without a proper provider-patient relationship. Section 6003 bars issuing a prescription solely in response to an internet questionnaire, internet consult, or telephone consult when no relationship has been established, and the relationship requires identity and location verification and disclosure of the provider's credentials. Section 6004(a) also requires, before diagnosis and treatment, an in-person exam, another Delaware-licensed provider present with you, a diagnosis made by audio or visual communication, or compliance with professional society guidelines for evidence-based telemedicine. [2]
What does an out-of-state pharmacy need to ship compounded peptides to Delaware?
A Delaware nonresident pharmacy license. The pharmacy must also designate a Delaware registered agent, keep its home-state license valid, and send the Board of Pharmacy its inspection reports. Check the Division of Professional Regulation license lookup before ordering. [1] [6]
Sources
- [1]Delaware Board of Pharmacy, Division of Professional Regulation
- [2]Delaware Code Title 24, chapter 60, Provisions applicable to telehealth and telemedicine
- [3]24 Del. C. 6003, Scope of practice; provider-patient relationship required
- [4]Delaware Division of Professional Regulation: medical interstate telehealth registrations
- [5]Delaware Code Title 24, chapter 25, Pharmacy
- [6]Delaware Code Title 24, chapter 25, subchapter IV, Pharmacies (nonresident pharmacy sections 2535 to 2537)
- [7]Delaware Administrative Code Title 24, 2500 Board of Pharmacy regulations (5.1.6 Compounding; 10.0 Pharmaceutical Compounding), accessed 2026-09-22
- [8]Delaware Code Title 16, chapter 33, Pure Food and Drugs (section 3302), accessed 2026-09-22
- [9]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
- [10]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
- [11]21 U.S.C. 331, Prohibited acts